Inhibitor Therapeutics

INTI

OTCHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-125.27K

EBITDA$-125.27K

EBIT$-125.27K

Pre-tax Income$-3.35M

Net Income$-132.36K

Cash Equivalent$46.86K

Total Debt$115.5K

Book Value$-1.76M

Book Value Per Share-0.01

Return on Equity (ROE)-168.22%

Return on Assets (ROA)-58.64%

Return on Invested Capital (ROI)-168.22%

Net Profit Margin-277.75%

Current Ratio8.02

Quick Ratio7.90

Long-Term Debt / Equity9.32